UNSPSC 51392603: Phenylpropanolamine

This classification denotes an adrenergic agonist with the molecular formula C9H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33RU150WUN, chemically known as 1r,2s-(-)-norephedrine hydrochloride but generally known as phenylpropanolamine, which bears US NIH Compound Identifier 4786. European Medicines Agency schedules Phenylpropanolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09790MIG.

UNSPSC 51392603 Phenylpropanolamine is a Commodity code that in recent state and local procurement shows little alignment with its nominal pharmaceutical scope. The two opportunities posted under this code in the past three months involve naloxone and drug deactivation systems (Seminole County, Florida) and a Texas Health and Human Services Commission request for information on direct-to-manufacturer prescription programs — neither of which is phenylpropanolamine procurement. The mismatch suggests that the code may be miscategorized in state and local systems, or that the opportunities were tagged incorrectly. Absent recent solicitations that actually target phenylpropanolamine itself, the code shows minimal relevant activity for firms seeking work in this pharmaceutical commodity.

The Seminole County opportunity (IFB 60459723LAS, response due July 26, 2023) is the only concrete purchase solicitation, calling for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The Texas HHS RFI (HHS0017013, posted April 3, 2026) is exploratory market research rather than a buy and does not represent immediate procurement demand. Geographic activity is confined to Florida and Texas based on these two records. Without substantive recent opportunities actually seeking phenylpropanolamine, the code does not present a clear procurement signal for business development purposes at this time.